CRO Engagement: A Compliance Checklist to Identify Red Flags and Prevent Bribery Compliance Risks

The engagement of Clinical Research Organizations (CROs) by pharmaceutical and medical device companies to manage some or all of their clinical trial-related duties and functions is becoming more and more relevant as the number of global clinical trials increases each year and the regulatory framework associated with clinical trials and subsequent commercial development of drugs and devices becomes more complex.